Patent · US Active

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer

US7906635B2 · kind B2 · utility

1Cited by

2References

8Claims

0Family size

Assignee

Compugen Ltd. · IL

Inventors

Gad S. Cojocaru · Ramat HaSharon, IL
Sarah Pollock · Nes Ziona, IL
Zurit Levine · Herzliya, IL
Alexander Diber · Rishon LeZion, IL
Guy Kol · Givat Shmuel, IL
Amir Toporik · Holon, IL
Rotem Sorek · Rehovot, IL
Dvir Dahary · Nes Ziona, IL
Michal Ayalon-Soffer · Ramat HaSharon, IL
Pinchas Akiva · Ramat Gan, IL
Amit Novik · Holon, IL
Yossi Cohen · Raanana, IL
Osnat Sella-Tavor · Ein Mahel, IL
Shira Walach · Hod HaSharon, IL
Shirley Sameah-Greenwald · Kfar Sava, IL
Ronen Shemesh · Holon, IL
Maxim Shklar · Nes Ziona, IL

Key dates

Filing date	Jan 15, 2009
Grant date	Mar 15, 2011
Priority date	—
Expiry date	Feb 7, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/143333
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.